Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
£10.00
|
|
Provider: Investcafe
|
£8.00
|
|
Provider: GlobalData
|
£81.00
|
|
Provider: Investcafe
|
£8.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
FAS Clears AFK Sistema OAO's Bid To Buy Stake In Veropharm OAO From Aptechnaya set' 36,6 OAO-Reuters
Reuters reported that Russia's anti-monopoly regulator FAS cleared AFK Sistema OAO's (Sistema) plan to buy 100% of voting shares in drug maker Veropharm OAO. Business daily Vedomosti reported that Sistema could pay between RUB 4.9 billion ($155 million) and RUB 5.7 billion to buy a 51.8% stake in Veropharm OAO from drug store group Aptechnaya set' 36,6 OAO (Pharmacy Chain 36.6).
Latest Developments for Verofarm OAO
Latest Key Developments in Pharmaceuticals
- USFDA Issues Warning Letter To RPG Life Sciences Ltd-Business Standard
- Alk Abello A/S Announces Positive Outcome of Pivotal Phase III Trial with Allergy Immunotherapy Tablet against House Dust Mite Allergy
- EU Fines Ranbaxy Laboratories Ltd And Others For Blocking Cheaper Drugs-Business Standard
- H Lundbeck A/S Lowers FY 2013 EBIT Guidance Following European Commission's Fine of EUR 93 Million-DJ
- Share this
- Link this
- Digg this
Follow Reuters